Rock Springs Capital Management LP cut its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 10.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 475,000 shares of the company's stock after selling 57,500 shares during the period. Rock Springs Capital Management LP owned approximately 1.04% of Azenta worth $23,750,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently modified their holdings of the company. Dimensional Fund Advisors LP raised its holdings in Azenta by 0.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,033,171 shares of the company's stock worth $151,659,000 after buying an additional 26,929 shares during the period. Conestoga Capital Advisors LLC increased its holdings in Azenta by 65.0% during the 4th quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock worth $78,894,000 after purchasing an additional 621,830 shares in the last quarter. Schroder Investment Management Group raised its stake in shares of Azenta by 46.7% in the 4th quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock valued at $70,183,000 after purchasing an additional 447,292 shares during the period. Allspring Global Investments Holdings LLC boosted its position in shares of Azenta by 1.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company's stock worth $65,922,000 after buying an additional 18,529 shares during the period. Finally, Federated Hermes Inc. grew its holdings in shares of Azenta by 65.9% during the fourth quarter. Federated Hermes Inc. now owns 762,189 shares of the company's stock worth $38,109,000 after buying an additional 302,786 shares in the last quarter. 99.08% of the stock is currently owned by institutional investors.
Azenta Trading Down 1.5 %
Shares of Azenta stock traded down $0.40 during trading on Friday, hitting $26.73. 603,236 shares of the stock were exchanged, compared to its average volume of 646,541. The company has a fifty day moving average price of $35.03 and a 200-day moving average price of $43.26. The stock has a market capitalization of $1.22 billion, a price-to-earnings ratio of -8.97 and a beta of 1.66. Azenta, Inc. has a 1-year low of $24.06 and a 1-year high of $63.58.
Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Equities research analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.
Analysts Set New Price Targets
Several research firms have commented on AZTA. Evercore ISI boosted their target price on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research note on Thursday, February 6th. Stephens restated an "overweight" rating and set a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. TD Cowen upgraded shares of Azenta to a "hold" rating in a research note on Thursday, February 27th. Finally, Needham & Company LLC raised their price objective on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a report on Thursday, February 6th.
Get Our Latest Stock Report on AZTA
Azenta Profile
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Further Reading

Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.